RH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the provided data, RH is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 investment capital. While the company has shown some positive financial growth, the technical indicators are bearish, insider selling is significantly high, and there are no strong immediate catalysts for price recovery. Holding off on buying is recommended until clearer upward momentum or stronger signals emerge.
The technical indicators for RH are bearish. The MACD histogram is negative (-5.535), RSI is extremely oversold at 13.029, and the moving averages (SMA_200 > SMA_20 > SMA_5) indicate a downward trend. The stock is trading below key support levels, with S1 at 147.71 and S2 at 132.121, suggesting further downside risk.
Kettle Hill Capital Management recently acquired 161,122 shares of RH, making it the fund's third-largest holding. The company reported a 10% revenue increase and a 64% rise in net income for the first nine months of fiscal 2025, indicating some operational strength.
Insiders have significantly increased their selling activity, with a 470.54% rise in the last month. Analysts have been lowering price targets, with some firms expressing concerns about demand, tariffs, and profitability. The stock has underperformed the S&P 500 by 57.9 percentage points over the past year.
In Q3 2026, RH reported an 8.88% YoY revenue increase to $883.81 million, a 9.34% YoY net income increase to $36.27 million, and a 10.24% YoY EPS growth to 1.83. However, gross margin dropped by 0.92% YoY to 44.1%, indicating some pressure on profitability.
Analysts are mixed but leaning cautious. Recent ratings include price target reductions from firms like Morgan Stanley ($250 from $300), JPMorgan ($225 from $275), and Stifel ($165 from $320). While some firms maintain 'Buy' or 'Overweight' ratings, the overall sentiment reflects concerns about demand, tariffs, and profitability challenges.
